We are pleased to inform you that the first trial participant was enrolled at the University Medical Center in Leiden on 10th of September 2021. Thank you for your great effort!
We are happy to inform you that the second patient was enrolled in the University Hospital of Geneva. Thank you for your excellent work!
We are happy to inform you that the first site, the Leiden University Medical Center (LUMC), in the Netherlands is open for accrual since July 7 2021. We wish the study team in Leiden good luck!